Back to Avoro Capital Advisors LLC Avoro Capital Advisors LLC

TGTX

3 quarters

Position history for Avoro Capital Advisors LLCAvoro Capital Advisors LLC's holdings in TG Therapeutics, Inc.

No. Avoro Capital Advisors exited its TGTX (TG Therapeutics) position in Q2 2020. Its Q1 2020 13F listed 800,000 shares worth $7.9M. Avoro Capital Advisors first reported TGTX in Q4 2019 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$11.1M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q2
Latest
Exited
0
-100.0%
$00.0%$19.48
0
2020-Q1
Decreased
800,000
-20.0%
$7.9M0.3%$9.84
0
2019-Q4
New
1M
-
$11.1M0.3%$11.10
47

Other major holders of TGTX: BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used